The future of clinical pharmacology in the UK

Lancet. 2006 Apr 1;367(9516):1051. doi: 10.1016/S0140-6736(06)68460-2.

Authors

Alasdair Breckenridge¹, Colin Dollery², Michael Rawlins³, Mark Walport⁴

Affiliations

¹ Medicines and Healthcare products Regulatory Agency, London SW8 5NQ, UK. Electronic address: alasdair.breckenridge@mhra.gsi.gov.uk.
² GlaxoSmithKline Research and Development, Harlow, Essex, UK.
³ National Institute for Health and Clinical Excellence, London, UK.
⁴ Wellcome Trust, London, UK.

PMID: 16581393
DOI: 10.1016/S0140-6736(06)68460-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Industry / trends*
Humans
Pharmacology, Clinical / trends*
United Kingdom